文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

2009 - 2014年美国医院中使用临床数据与索赔数据的脓毒症发病率及趋势

Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014.

作者信息

Rhee Chanu, Dantes Raymund, Epstein Lauren, Murphy David J, Seymour Christopher W, Iwashyna Theodore J, Kadri Sameer S, Angus Derek C, Danner Robert L, Fiore Anthony E, Jernigan John A, Martin Greg S, Septimus Edward, Warren David K, Karcz Anita, Chan Christina, Menchaca John T, Wang Rui, Gruber Susan, Klompas Michael

机构信息

Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Health Care Institute, Boston, Massachusetts.

Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

出版信息

JAMA. 2017 Oct 3;318(13):1241-1249. doi: 10.1001/jama.2017.13836.


DOI:10.1001/jama.2017.13836
PMID:28903154
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5710396/
Abstract

IMPORTANCE: Estimates from claims-based analyses suggest that the incidence of sepsis is increasing and mortality rates from sepsis are decreasing. However, estimates from claims data may lack clinical fidelity and can be affected by changing diagnosis and coding practices over time. OBJECTIVE: To estimate the US national incidence of sepsis and trends using detailed clinical data from the electronic health record (EHR) systems of diverse hospitals. DESIGN, SETTING, AND POPULATION: Retrospective cohort study of adult patients admitted to 409 academic, community, and federal hospitals from 2009-2014. EXPOSURES: Sepsis was identified using clinical indicators of presumed infection and concurrent acute organ dysfunction, adapting Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) criteria for objective and consistent EHR-based surveillance. MAIN OUTCOMES AND MEASURES: Sepsis incidence, outcomes, and trends from 2009-2014 were calculated using regression models and compared with claims-based estimates using International Classification of Diseases, Ninth Revision, Clinical Modification codes for severe sepsis or septic shock. Case-finding criteria were validated against Sepsis-3 criteria using medical record reviews. RESULTS: A total of 173 690 sepsis cases (mean age, 66.5 [SD, 15.5] y; 77 660 [42.4%] women) were identified using clinical criteria among 2 901 019 adults admitted to study hospitals in 2014 (6.0% incidence). Of these, 26 061 (15.0%) died in the hospital and 10 731 (6.2%) were discharged to hospice. From 2009-2014, sepsis incidence using clinical criteria was stable (+0.6% relative change/y [95% CI, -2.3% to 3.5%], P = .67) whereas incidence per claims increased (+10.3%/y [95% CI, 7.2% to 13.3%], P < .001). In-hospital mortality using clinical criteria declined (-3.3%/y [95% CI, -5.6% to -1.0%], P = .004), but there was no significant change in the combined outcome of death or discharge to hospice (-1.3%/y [95% CI, -3.2% to 0.6%], P = .19). In contrast, mortality using claims declined significantly (-7.0%/y [95% CI, -8.8% to -5.2%], P < .001), as did death or discharge to hospice (-4.5%/y [95% CI, -6.1% to -2.8%], P < .001). Clinical criteria were more sensitive in identifying sepsis than claims (69.7% [95% CI, 52.9% to 92.0%] vs 32.3% [95% CI, 24.4% to 43.0%], P < .001), with comparable positive predictive value (70.4% [95% CI, 64.0% to 76.8%] vs 75.2% [95% CI, 69.8% to 80.6%], P = .23). CONCLUSIONS AND RELEVANCE: In clinical data from 409 hospitals, sepsis was present in 6% of adult hospitalizations, and in contrast to claims-based analyses, neither the incidence of sepsis nor the combined outcome of death or discharge to hospice changed significantly between 2009-2014. The findings also suggest that EHR-based clinical data provide more objective estimates than claims-based data for sepsis surveillance.

摘要

重要性:基于索赔分析的估计表明,脓毒症的发病率在上升,而脓毒症的死亡率在下降。然而,基于索赔数据的估计可能缺乏临床准确性,并且可能会受到随时间变化的诊断和编码实践的影响。 目的:使用来自不同医院电子健康记录(EHR)系统的详细临床数据,估计美国全国脓毒症的发病率和趋势。 设计、设置和人群:对2009年至2014年入住409家学术、社区和联邦医院的成年患者进行回顾性队列研究。 暴露因素:使用假定感染的临床指标和并发的急性器官功能障碍来识别脓毒症,采用《脓毒症和脓毒性休克第三次国际共识定义》(Sepsis-3)标准进行基于EHR的客观且一致的监测。 主要结局和指标:使用回归模型计算2009年至2014年的脓毒症发病率、结局和趋势,并与使用《国际疾病分类,第九次修订本,临床修订版》严重脓毒症或脓毒性休克编码的基于索赔的估计值进行比较。通过病历审查,根据Sepsis-3标准对病例发现标准进行验证。 结果:在2014年入住研究医院的2901019名成年人中,使用临床标准共识别出173690例脓毒症病例(平均年龄66.5岁[标准差15.5岁];77660例[42.4%]为女性)(发病率6.0%)。其中,26061例(15.0%)在医院死亡,10731例(6.2%)出院后进入临终关怀。从2009年至2014年,使用临床标准的脓毒症发病率稳定(相对变化+0.6%/年[95%置信区间,-2.3%至3.5%],P = 0.67),而基于索赔的发病率上升(+10.3%/年[95%置信区间,7.2%至13.3%],P < 0.001)。使用临床标准的住院死亡率下降(-3.3%/年[95%置信区间,-5.6%至-1.0%],P = 0.004),但死亡或出院后进入临终关怀的综合结局无显著变化(-1.3%/年[95%置信区间,-3.2%至0.6%],P = 0.19)。相比之下,基于索赔的死亡率显著下降(-7.0%/年[95%置信区间,-8.8%至-5.2%],P < 0.001),死亡或出院后进入临终关怀的情况也是如此(-4.5%/年[95%置信区间,-6.1%至-2.8%],P < 0.001)。临床标准在识别脓毒症方面比索赔更敏感(69.7%[95%置信区间,52.9%至92.0%]对32.3%[95%置信区间,24.4%至43.0%],P < 0.001),阳性预测值相当(70.4%[95%置信区间,64.0%至76.8%]对75.2%[95%置信区间,69.8%至80.6%],P = 0.23)。 结论与意义:在409家医院的临床数据中,6%的成年住院患者存在脓毒症,与基于索赔的分析不同,2009年至2014年期间脓毒症的发病率以及死亡或出院后进入临终关怀的综合结局均无显著变化。研究结果还表明,基于EHR的临床数据在脓毒症监测方面比基于索赔的数据提供了更客观的估计。

相似文献

[1]
Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014.

JAMA. 2017-10-3

[2]
Objective Sepsis Surveillance Using Electronic Clinical Data.

Infect Control Hosp Epidemiol. 2016-2

[3]
Estimating Ten-Year Trends in Septic Shock Incidence and Mortality in United States Academic Medical Centers Using Clinical Data.

Chest. 2017-2

[4]
Variation in Identifying Sepsis and Organ Dysfunction Using Administrative Versus Electronic Clinical Data and Impact on Hospital Outcome Comparisons.

Crit Care Med. 2019-4

[5]
Trends in sepsis and infection sources in the United States. A population-based study.

Ann Am Thorac Soc. 2015-2

[6]
Mortality Trends for Veterans Hospitalized With Heart Failure and Pneumonia Using Claims-Based vs Clinical Risk-Adjustment Variables.

JAMA Intern Med. 2020-3-1

[7]
Use of Electronic Clinical Data to Track Incidence and Mortality for SARS-CoV-2-Associated Sepsis.

JAMA Netw Open. 2023-9-5

[8]
Improving documentation and coding for acute organ dysfunction biases estimates of changing sepsis severity and burden: a retrospective study.

Crit Care. 2015-9-14

[9]
Identification of Pediatric Sepsis for Epidemiologic Surveillance Using Electronic Clinical Data.

Pediatr Crit Care Med. 2020-2

[10]
Association of diagnostic coding with trends in hospitalizations and mortality of patients with pneumonia, 2003-2009.

JAMA. 2012-4-4

引用本文的文献

[1]
Identification of sepsis biomarkers through glutamine metabolism-mediated immune regulation: a comprehensive analysis employing mendelian randomization, multi-omics integration, and machine learning.

Front Immunol. 2025-8-20

[2]
Friend or foe: the gut microbiota as a modulator of disease trajectory in trauma, surgery, and critical illness.

Gut Microbes. 2025-12

[3]
Real-World Outcomes and Prognostic Factors of Polymyxin B Hemoperfusion in Severe Sepsis and Septic Shock: A Seven-Year Single-Center Cohort Study from Taiwan.

Life (Basel). 2025-8-20

[4]
Serum proteomes and their prognostic values in sepsis patients admitted to a medical intensive care unit: a single-center study using SWATH-MS proteomics.

Ann Intensive Care. 2025-8-27

[5]
Multivariate protein landscape of host response in hospitalised patients with suspected infection in the emergency department.

Nat Commun. 2025-8-22

[6]
Vasopressin Initiation Timing and In-Hospital Mortality in Septic Shock: An Observational Study of Large Public Databases.

Crit Care Explor. 2025-8-22

[7]
Development and validation of an interpretable machine learning model for retrospective identification of suspected infection for sepsis surveillance: a multicentre cohort study.

EClinicalMedicine. 2025-8-8

[8]
Evaluating the diagnostic performance of adult sepsis event criteria in the emergency department: impact of including isolated serum lactate elevations.

J Intensive Care. 2025-8-15

[9]
The Prognostic Utility of Pathophysiologically Distinct Biomarkers for Renal Outcomes in Sepsis: A Prospective ICU Cohort Study.

J Clin Med. 2025-7-30

[10]
Pragmatic, multicentre, factorial, randomised controlled trial of sepsis electronic prompting for timely intervention and care (SEPTIC trial): a protocol.

BMJ Open. 2025-8-11

本文引用的文献

[1]
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.

Crit Care Med. 2017-3

[2]
Sepsis and the theory of relativity: measuring a moving target with a moving measuring stick.

Crit Care. 2016-11-21

[3]
Trend in Ventilator-Associated Pneumonia Rates Between 2005 and 2013.

JAMA. 2016-12-13

[4]
Estimating Ten-Year Trends in Septic Shock Incidence and Mortality in United States Academic Medical Centers Using Clinical Data.

Chest. 2017-2

[5]
We Need Better Tools for Sepsis Surveillance.

Crit Care Med. 2016-7

[6]
Diagnosing sepsis is subjective and highly variable: a survey of intensivists using case vignettes.

Crit Care. 2016-4-6

[7]
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

JAMA. 2016-2-23

[8]
Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

JAMA. 2016-2-23

[9]
Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

JAMA. 2016-2-23

[10]
Application of a Framework to Assess the Usefulness of Alternative Sepsis Criteria.

Crit Care Med. 2016-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索